fludarabine phosphate 50 milligram pdr for soln inj/inf
bayer limited - fludarabine phosphate - pdr for soln inj/inf - 50 milligram
fludara oral fludarabine phosphate 10mg tablet blister pack
sanofi-aventis australia pty ltd - fludarabine phosphate, quantity: 10 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; purified talc; titanium dioxide; iron oxide yellow; iron oxide red - indicated for use as second-line tharapy in patients with chronic lymphocytic leukaemia (cll). indications as at 6 april 2004: for the treatment of b-cell chronic lymphocytic leukaemia.
fludarabine phosphate 50 mg/vial for injection
hospira australia pty ltd - fludarabine phosphate -
fludarabine accord healthcare 25 mg/ml inj./inf. sol. (conc.) i.v. vial
accord healthcare b.v. - fludarabine phosphate 25 mg/ml - concentrate for solution for injection/infusion - 25 mg/ml - fludarabine phosphate 25 mg/ml - fludarabine
fludarabine sandoz 25 mg/ml inj./inf. sol. (conc.) i.v. vial
sandoz sa-nv - fludarabine phosphate 50 mg/2 ml - concentrate for solution for injection/infusion - 25 mg/ml - fludarabine phosphate 25 mg/ml - fludarabine
fludarabine teva 25 mg/ml inj./inf. sol. (conc.) i.v. vial
teva pharma belgium sa-nv - fludarabine phosphate 25 mg/ml - concentrate for solution for injection/infusion - 25 mg/ml - fludarabine phosphate 25 mg/ml - fludarabine
fludarabin ebewe 50 mg2 ml
novartis israel ltd - fludarabine phosphate - concentrate for solution for injection / infusion - fludarabine phosphate 50 mg/dose - fludarabine - fludarabine - palliative treatment of patients with cll refractory to other therapy. treatment of less malignant non-hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. fludarabine is indicated for the initial treatment of patients with b- cell chronic lymphocytic leukaemia (cll) or after first line therapy, in patients with sufficient bone marrow reserves.
as-fludarabine fludarabine phosphate 50 mg/2 ml concentrated injection vial
alphapharm pty ltd - fludarabine phosphate, quantity: 50 mg - injection, concentrated - excipient ingredients: water for injections; sodium hydroxide; mannitol - treatment of b-cell chronic lymphocytic leukaemia.
as-fludarabine fludarabine phosphate 50 mg powder for injection vial
alphapharm pty ltd - fludarabine phosphate, quantity: 50 mg - injection, powder for - excipient ingredients: mannitol; sodium hydroxide - treatment of b-cell chronic lymphocytic leukaemia.
hospira fludarabine phosphate for injection, usp 50 mg/vial
hospira australia pty ltd - fludarabine phosphate -